Special Issue: Seminars in Hematology: Impact and Future of Social Media Utilization Among Healthcare Stakeholders in the Field of Hematology and Oncology
Based on data from the Pew Research Center, approximately 70% of Americans are using social media platforms for connection and communication [1,2]. Remarkably, in 2005, at the time this information was first collected, only 5% of Americans were engaging in social media [1]. Additionally, it is becoming increasingly clear that communication via the Internet and social media are mainstays of of the modern medical era, both in clinical practice [3] as well for both the conduction and reporting of academic medical research [4,5]. (Source: Seminars in Hematology)
Source: Seminars in Hematology - August 25, 2017 Category: Hematology Authors: Naveen Pemmaraju Source Type: research
The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette
The use of social media, and in particular, Twitter, for professional use among healthcare providers is rapidly increasing across the world. One medical subspecialty that is leading the integration of this new platform for communication into daily practice and for information dissemination to the general public is the field of hematology/oncology. A growing amount of research in this area demonstrates that there is increasing interest among physicians to learn not only how to use social media for consumption of educational material, but also how to generate and contribute original content in one ’s interest/expert areas....
Source: Seminars in Hematology - August 24, 2017 Category: Hematology Authors: Naveen Pemmaraju, Ruben A. Mesa, Navneet S. Majhail, Michael A. Thompson Source Type: research
The Use and Impact of Twitter at Medical Conferences: Best Practices and Twitter Etiquette
The use of social media, and in particular, Twitter, for professional use among healthcare providers is rapidly increasing across the world. One medical subspecialty that is leading the integration of this new platform for communication into daily practice and for information dissemination to the general public is the field of hematology/oncology. A growing amount of research in this area demonstrates that there is increasing interest among physicians to not only learn how to use social media for consumption of educational material, but also to learn how to generate and contribute original content in one ’s interest/expe...
Source: Seminars in Hematology - August 24, 2017 Category: Hematology Authors: Naveen Pemmaraju, Ruben A. Mesa, Navneet S. Majhail, Michael A. Thompson Tags: Impact of Social Media for the Hematologist/Oncologist Source Type: research
Individual risk assessment in MDS in the era of genomic medicine
Assessment of risk for patients with myelodysplastic syndromes has evolved from pure morphological bone marrow assessment to a series of validated prognostic scoring systems whose ‘risk’ assessment is of death (overall survival) or disease progression (AML transformation). The revised International Prognostic Scoring System (2012) improved the precision for prognosis but did not consider patient-specific factors such as comorbidity and performance status, which have a cle ar impact on outcome, particularly in lower-risk MDS. (Source: Seminars in Hematology)
Source: Seminars in Hematology - August 22, 2017 Category: Hematology Authors: Catherine Cargo, David Bowen Tags: 54/3 Therapies in MDS Source Type: research
Primary thromboembolic prevention in multiple myeloma patients: An exploratory meta-analysis on aspirin use
Multiple myeloma (MM) is a common hematological disorder, often complicated by venous thromboembolism, especially during treatment with immunomodulatory drugs. Acetylsalicylic acid (ASA) has been extensively used as thromboprophylaxis but its rationale is unclear and the efficacy versus low-molecular weight heparins (LMWH) is still matter of debate. European and American guidelines suggest different approaches and the optimal antithrombotic strategy is yet to be established. (Source: Seminars in Hematology)
Source: Seminars in Hematology - August 11, 2017 Category: Hematology Authors: Giacomo Zoppellaro, Nicola Veronese, Serena Granziera, Laura Gobbi, Brendon Stubbs, Alexander T. Cohen Source Type: research
Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine
Twitter use by physicians, including those in the hematology –oncology field, is increasing. This microblogging platform provides a means to communicate and collaborate on a global scale. For the oncology professional, an active Twitter presence provides opportunities for continuing medical education, patient engagement and education, personal branding, and reputation management. However, because Twitter is an open, public forum, potential risks such as patient privacy violations, personal information disclosures, professionalism lapses, and time management need to be considered and managed. (Source: Seminars in Hematology)
Source: Seminars in Hematology - August 11, 2017 Category: Hematology Authors: Deanna J. Attai, Patricia F. Anderson, Michael J. Fisch, David L. Graham, Matthew S. Katz, Jennifer Kesselheim, Merry Jennifer Markham, Nathan A. Pennell, Mina S. Sedrak, Michael A. Thompson, Audun Utengen, Don S. Dizon, for the Collaboration for Outcomes Source Type: research
Primary thromboembolic prevention in multiple myeloma patients: an exploratory meta-analysis on aspirin use
Dear Sirs, (Source: Seminars in Hematology)
Source: Seminars in Hematology - August 11, 2017 Category: Hematology Authors: Giacomo Zoppellaro, Veronese Nicola, Serena Granziera, Laura Gobbi, Brendon Stubbs, Alexander T. Cohen Source Type: research
Risks and Benefits of Twitter Use by Hematologists / Oncologists in the Era of Digital Medicine
Twitter use by physicians, including those in the hematology – oncology field, is increasing. This microblogging platform provides a means to communicate and collaborate on a global scale. For the oncology professional, an active Twitter presence provides opportunities for continuing medical education, patient engagement and education, personal branding, an d reputation management. However, because Twitter is an open, public forum, potential risks such as patient privacy violations, personal information disclosures, professionalism lapses, and time management need to be considered and managed. (Source: Seminars in Hematology)
Source: Seminars in Hematology - August 11, 2017 Category: Hematology Authors: Deanna J. Attai, Patricia F. Anderson, Michael J. Fisch, David L. Graham, Matthew S. Katz, Jennifer Kesselheim, Merry Jennifer Markham, Nathan A. Pennell, Mina S. Sedrak, Michael A. Thompson, Audun Utengen, Don S. Dizon, Collaboration for Outcomes on Soci Tags: 54/4 Impact of Social Media for the Hematologist/Oncologist Source Type: research
Introduction
Myelodysplastic syndromes (MDS) are defined in the World Health Organization (WHO) classification of tumors of hematopoietic and lymphoid tissues as a group of clonal hematopoietic stem cell diseases characterized by cytopenia, dysplasia in one or more of the major myeloid cell lines, ineffective hematopoiesis, and increased risk of progression to acute myeloid leukemia (AML).1 (Source: Seminars in Hematology)
Source: Seminars in Hematology - July 20, 2017 Category: Hematology Authors: Luca Malcovati Source Type: research
Therapeutic Targeting of RNA Splicing in Myelodysplasia
Genomic analysis of patients with myelodysplastic syndromes (MDS) has identified that mutations within genes encoding RNA splicing factors represent the most common class of genetic alterations in MDS. These mutations primarily affect SF3B1, SRSF2, U2AF1, and ZRSR2. Current data suggest that these mutations perturb RNA splicing catalysis in a manner distinct from loss of function but how exactly the global changes in RNA splicing imparted by these mutations result in MDS is not well delineated. At the same time, cells bearing mutations in RNA splicing factors are exquisitely dependent on the presence of the remaining wildt...
Source: Seminars in Hematology - July 12, 2017 Category: Hematology Authors: Young Joon Kim, Omar Abdel-Wahab Source Type: research
Twitter 101 and beyond: introduction to social media platforms available to practicing hematologist/oncologists
Social media utilizes specific media platforms to allow increased interactivity between participants. These platforms serve diverse groups and purposes including participation from patients, family caregivers, research scientists, physicians, and pharmaceutical companies. Utilization of these information outlets has increased with integration at conferences and between conferences with the use of hashtags and “chats”. In the realm of the “e-Patient” it is key to not underestimate your audience. Highly technical information is just as useful as a basic post. (Source: Seminars in Hematology)
Source: Seminars in Hematology - July 11, 2017 Category: Hematology Authors: Michael A. Thompson, Jenny Ahlstrom, Don S. Dizon, Yash Gad, Greg Matthews, Howard J. Luks, Andrew Schorr Source Type: research
Twitter 101 & beyond: Introduction to social media platforms available to practicing hematologist/oncologists
Social media utilizes specific media platforms to allow increased interactivity between participants. These platforms serve diverse groups and purposes including participation from patients, family caregivers, research scientists, physicians, pharmaceutical companies. Utilization of these information outlets has increased with integration at conferences and between conferences with the use of hashtags and “chats”. In the realm of the “e-Patient” it is key to not underestimate your audience. Highly technical information is just as useful as a basic post. (Source: Seminars in Hematology)
Source: Seminars in Hematology - July 11, 2017 Category: Hematology Authors: Michael A. Thompson, Jenny Ahlstrom, Don S. Dizon, Yash Gad, Greg Matthews, Howard J. Luks, Andrew Schorr Source Type: research
